Showing results (1-10 of 128) with videos related to
Sort By:
Pageof 13
Oncology|June 10, 2008
Dose escalation study of amrubicin in combination with fixed-dose irinotecan in patients with extensive small-cell lung cancerFumihiro Oshita, Haruhiro Saito, Kouzo YamadaJournal of Experimental Therapeutics & Oncology|June 8, 2007
Feasible combination chemotherapy with nedaplatin and irinotecan for patients with non-small cell lung cancer and multiple high-risk factorsFumihiro Oshita, Haruhiro Saito, Kouzo YamadaJournal of Clinical Medicine|April 12, 2022
Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerRyota Ushio, Shuji Murakami, Haruhiro SaitoAmerican Journal of Clinical Oncology|September 1, 2007
Phase II study of paclitaxel and irinotecan chemotherapy in patients with advanced nonsmall cell lung cancerFumihiro Oshita, Haruhiro Saito, Kouzo Yamada, et al.Cancer Chemotherapy and Pharmacology|October 26, 2007
Phase II study of nedaplatin and irinotecan followed by gefitinib for elderly patients with unresectable non-small cell lung cancerFumihiro Oshita, Kouzo Yamada, Haruhiro Saito, et al.Thoracic Cancer|August 29, 2023
Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M-positive: Case report and literature reviewChihiro Maeda, Kanako Shinada, Shuji Murakami, et al.American Journal of Clinical Oncology|September 30, 2009
Phase II study of paclitaxel and irinotecan with intercalated gefitinib in patients with advanced non-small-cell lung cancerFumihiro Oshita, Haruhiro Saito, Shuji Murakami, et al.Frontiers in Oncology|April 28, 2023
Case report: anaplastic lymphoma kinase (ALK) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumabNaoko Shigeta, Shuji Murakami, Tomoyuki Yokose, et al.Journal of Experimental Therapeutics & Oncology|December 28, 2019
Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-typeShuji Murakami, Haruhiro Saito, Tetsuro Kondo, et al.Journal of Experimental Therapeutics & Oncology|January 15, 2014
Prospective study of paclitaxel and irinotecan for elderly patients with unresectable non-small cell lung cancerFumihiro Oshita, Shuji Murakami, Tetsuro Kondo, et al.Pageof 13